title: How many patients and how many complications does it take to decide if a drug is safe to use before surgery?
authors.forename: M Margaret
authors.initials: MM
authors.lastname: Kemeny
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006498:Hepatectomy; D006801:Humans; D007239:Infections / Q000139:chemically induced / Q000209:etiology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D011183:Postoperative Complications / Q000139:chemically induced / Q000209:etiology; D013529:Surgical Wound Dehiscence / Q000139:chemically induced / Q000209:etiology; D013530:Surgical Wound Infection / Q000139:chemically induced / Q000209:etiology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab